Tham, S.M.; Rahmat, J.N.; Chiong, E.; Wu, Q.; Esuvaranathan, K.; Mahendran, R.
Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model. Biomedicines 2021, 9, 1766.
https://doi.org/10.3390/biomedicines9121766
AMA Style
Tham SM, Rahmat JN, Chiong E, Wu Q, Esuvaranathan K, Mahendran R.
Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model. Biomedicines. 2021; 9(12):1766.
https://doi.org/10.3390/biomedicines9121766
Chicago/Turabian Style
Tham, Sin Mun, Juwita N. Rahmat, Edmund Chiong, Qinghui Wu, Kesavan Esuvaranathan, and Ratha Mahendran.
2021. "Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model" Biomedicines 9, no. 12: 1766.
https://doi.org/10.3390/biomedicines9121766
APA Style
Tham, S. M., Rahmat, J. N., Chiong, E., Wu, Q., Esuvaranathan, K., & Mahendran, R.
(2021). Intravesical High Dose BCG Tokyo and Low Dose BCG Tokyo with GMCSF+IFN α Induce Systemic Immunity in a Murine Orthotopic Bladder Cancer Model. Biomedicines, 9(12), 1766.
https://doi.org/10.3390/biomedicines9121766